查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1784171

全球皮下给药装置市场

Subcutaneous Drug Delivery Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 277 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球皮下给药装置市场规模将达 454 亿美元

全球皮下给药装置市场规模预计在2024年为325亿美元，到2030年将达到454亿美元，在2024-2030年的分析期间内，复合年增长率为5.7%。作为本报告分析的细分市场之一，预填充式注射器年增长率预计将达到4.8%，到分析期结束时市场规模将达到161亿美元。笔式註射器细分市场在分析期间的复合年增长率预计将达到6.0%。

美国市场规模估计为 89 亿美元，中国市场预期复合年增长率为 8.9%

美国皮下给药装置市场规模预计2024年达到89亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到91亿美元，在2024-2030年的分析期间内，复合年增长率为8.9%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为2.9%和5.6%。在欧洲，预计德国市场的复合年增长率为3.7%。

全球皮下给药装置市场－主要趋势与驱动因素摘要

家庭医疗保健的转变会推动设备创新吗？

人们对家庭医疗保健和自我给药的日益增长的偏好是推动皮下给药设备市场变革的关键因素。这些允许直接皮下给药的设备正在成为必不可少的工具，特别是对于管理糖尿病、类风湿性关节炎、多发性硬化症和荷尔蒙缺乏症等慢性疾病。随着世界各地的医疗保健系统寻求减轻医院和门诊诊所的负担，患者越来越多地使用易于使用、微创的输送系统来管理他们的家庭治疗。大流行进一步加速了这一趋势，许多患者和医疗保健提供者采用远端监控和自我给药作为标准做法。皮下给药比静脉注射有优势，包括持续释放药物、使用方便和依从性提高。穿戴式註射器、笔式註射器、自动注射器和微针贴片的发展扩大了治疗范围和患者群。如今，这些设备的设计充分考虑了人类工程学，强调舒适性、谨慎性和易用性，适用于包括儿科和老年患者在内的不同人群。随着设备介面变得更加直观，并整合了数位回馈和追踪功能，医疗设备与消费技术之间的界线日益模糊。医疗服务提供者、保险公司和监管机构越来越认可分散式医疗带来的长期成本效益和病患疗效，这也推动了这一趋势的发展。

为什么生物製药公司大力押注皮下注射途径？

生物製药公司越来越青睐皮下给药，而非传统的静脉注射注射，因为皮下给药可望提高患者依从性、延长专利生命週期并实现门诊治疗模式。由于生技药品和生物相似药在慢性和危及生命的疾病治疗中发挥核心作用，皮下给药的兼容性已成为一项策略重点。曾经仅限于输液中心给药的大分子药物，如今正被改造为皮下给药，显着提高了患者的便利性并降低了相关的医疗保健成本。单株抗体和免疫疗法等重磅药物皮下给药的获批，核准了器械开发领域的投资和合作激增。药械组合产品越来越多地在药物製剂早期进行联合开发，以确保最佳的药物动力学、剂量准确性和易用性。该产业也正在探索固定剂量组合、长效注射剂和缓释性系统。这些创新尤其适用于肿瘤学、内分泌学和罕见疾病，因为这些疾病的治疗顺从性至关重要。此外，皮下给药减少了给药过程中对训练有素的医务人员的需求，使医疗保健提供者能够更有效地配置资源。生物製药公司的兴趣也反映了竞争动态，在竞争激烈的治疗层级中，提供一种方便患者的居家给药方法可能成为关键的差异化因素。

数位健康和连结性会改变这些设备的未来吗？

数位化转型正在迅速改变皮下给药设备的格局。医疗技术与数位健康的融合，使连网型设备能够实现即时监控、个人化治疗方法和主动医疗管理。配备蓝牙和NFC功能的智慧注射器现在可以追踪给药时间、监测患者依从性，并将数据同步到患者和医疗专业人员均可存取的行动应用程式和云端平台。这种整合在管理复杂的慢性疾病方面尤其重要，因为服药依从性差会导致健康状况不佳和医疗成本增加。透过提供即时提醒、剂量警报和回馈机制，智慧给药系统在赋能患者的同时，也为护理团队提供了切实可行的建议。此外，人工智慧和机器学习演算法正在接受测试，以预测疾病发作并根据患者数据趋势优化给药方案。设备开发商也在与监管机构密切合作，以确保资料隐私和合规性，尤其是在《健康保险流通与责任法》(HIPAA) 和《一般资料保护规范》(GDPR) 等框架下。使用智慧给药系统进行远端患者监护正获得保险公司和综合医疗服务提供者的支持，他们看到了最大限度地减少就诊次数和实现基于结果的报销模式的价值。这种数位化变革不仅是技术升级，更是护理模式的转变，皮下给药成为病人、医疗保健提供者和数据生态系统之间的动态介面。

是什么推动了全球市场的成长轨迹？

皮下给药装置市场的成长受到多种因素的驱动，这些因素源自于治疗进展、病患行为、技术进步以及不断发展的医疗基础设施。全球慢性病（尤其是糖尿病、自体免疫疾病和癌症）的盛行率不断上升，对长期频繁给药的需求持续成长，使得皮下给药成为首选途径。已开发市场人口老化，加上新兴经济体中阶的崛起，正在推动对自主给药的需求。患者的偏好正明显转向非侵入性、省时且谨慎的解决方案，以最大限度地减少就诊次数并最大程度地提高患者自主性。在技术方面，生技药品创新使得大分子的皮下给药成为可能，而设备製造商正在推出可客製化且符合人体工学的设计，以满足更广泛的使用者群体。生物相似药和联合治疗的兴起也刺激了对创新剂型的需求。同时，政府和私人保险公司正在鼓励自主给药以控制不断上涨的医疗成本，这进一步推动了市场的发展势头。此外，专科药局和直销模式的蓬勃发展，也使得这些设备更加触手可及。监管部门以加快核准医疗设备组合产品的形式提供支持，促进了市场准入，而製药公司和医疗技术公司之间的行业合作也加速了创新。这些因素共同推动了成熟市场和新兴市场的强劲持续扩张。

部分

产品（预填充式注射器、笔式註射器、自动注射器、穿戴式註射器、无针注射器）、通路（医院药局、零售药局、网路药局）

受访公司范例

  • 3M
  • AbbVie
  • Amgen
  • AstraZeneca
  • Bayer
  • Becton, Dickinson and Company（BD）
  • Consort Medical Plc
  • Convatec Group
  • Dexcom
  • Elcam Medical Group
  • Eli Lilly and Company
  • Enable Injections
  • Gerresheimer AG
  • Halozyme Therapeutics
  • Inolife Sciences
  • Insulet Corporation
  • Johnson & Johnson
  • Medtronic Plc
  • Merck & Co.
  • Novo Nordisk
  • Pfizer
  • PharmaJet
  • Roche
  • Sanofi
  • Smith & Nephew
  • Terumo Corporation
  • Unilife Corporation
  • United Therapeutics
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global 特定产业产业SLM 的典型规范，而是建立了一个从世界各地专家收集的内容库，包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP33068

Global Subcutaneous Drug Delivery Devices Market to Reach US$45.4 Billion by 2030

The global market for Subcutaneous Drug Delivery Devices estimated at US$32.5 Billion in the year 2024, is expected to reach US$45.4 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2024-2030. Prefilled syringes, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$16.1 Billion by the end of the analysis period. Growth in the Pen injectors segment is estimated at 6.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.9 Billion While China is Forecast to Grow at 8.9% CAGR

The Subcutaneous Drug Delivery Devices market in the U.S. is estimated at US$8.9 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$9.1 Billion by the year 2030 trailing a CAGR of 8.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.9% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Subcutaneous Drug Delivery Devices Market - Key Trends & Drivers Summarized

How Is the Shift Toward Home-Based Healthcare Fueling Device Innovation?

The increasing preference for home-based healthcare and self-administration of drugs is a pivotal factor transforming the subcutaneous drug delivery devices market. These devices, which allow for the injection of medication directly under the skin, are becoming essential tools in chronic disease management-particularly for conditions such as diabetes, rheumatoid arthritis, multiple sclerosis, and hormone deficiencies. As healthcare systems globally seek to reduce the burden on hospitals and outpatient clinics, patients are being empowered to manage their treatment at home using user-friendly and minimally invasive delivery systems. The pandemic further accelerated this trend, with many patients and providers adopting remote monitoring and self-administration as standard practice. Subcutaneous delivery offers advantages such as sustained drug release, ease of use, and improved compliance compared to intravenous methods. The development of wearable injectors, pen injectors, autoinjectors, and micro-needle patches has widened the therapeutic scope and patient base. These devices are now designed with human factors engineering in mind, focusing on comfort, discretion, and usability for diverse populations, including pediatric and geriatric patients. As device interfaces become more intuitive and integrate digital feedback or tracking features, the line between medical device and consumer tech continues to blur. The trend is supported by growing acceptance among healthcare providers, insurance companies, and regulators who recognize the long-term cost benefits and patient outcomes associated with decentralized care.

Why Is Biopharma Betting Big on Subcutaneous Delivery Routes?

Biopharmaceutical companies are increasingly favoring subcutaneous delivery over traditional intravenous routes due to its potential for improving patient compliance, extending patent lifecycles, and enabling outpatient treatment models. As biologics and biosimilars take center stage in the treatment of chronic and life-threatening conditions, their compatibility with subcutaneous administration has become a strategic priority. Large molecule drugs, once limited to infusion centers, are now being reformulated for subcutaneous delivery, significantly enhancing patient convenience and reducing associated healthcare costs. The regulatory approval of subcutaneous versions of blockbuster drugs-such as monoclonal antibodies and immunotherapies-has sparked a wave of investment and partnership in device development. Drug-device combination products are now being co-developed early in the drug formulation process, ensuring optimal pharmacokinetics, dosing accuracy, and ease of use. The industry is also exploring fixed-dose combinations, long-acting injectables, and sustained-release systems tailored to subcutaneous use. These innovations are especially relevant for oncology, endocrinology, and rare diseases where treatment adherence is crucial. Furthermore, subcutaneous delivery is reducing the need for trained medical personnel during administration, allowing healthcare providers to allocate resources more efficiently. Biopharma’s interest also reflects competitive dynamics, where offering an at-home, patient-friendly delivery method can serve as a key differentiator in crowded therapeutic classes.

Are Digital Health and Connectivity Reshaping the Future of These Devices?

Digital transformation is rapidly reshaping the landscape of subcutaneous drug delivery devices. With the convergence of medical technology and digital health, connected devices are enabling real-time monitoring, personalized treatment regimens, and proactive healthcare management. Smart injectors equipped with Bluetooth or NFC capabilities can now track dosage timing, monitor patient adherence, and sync data with mobile apps or cloud platforms accessible to both patients and healthcare professionals. These integrations are particularly valuable in managing complex chronic conditions where non-adherence leads to poor health outcomes and increased healthcare costs. By offering real-time reminders, dosing alerts, and feedback mechanisms, smart delivery systems are empowering patients while creating actionable insights for care teams. Moreover, artificial intelligence and machine learning algorithms are being tested to predict flare-ups or optimize dosing schedules based on patient data trends. Device developers are also working closely with regulatory bodies to ensure data privacy and compliance, particularly under frameworks such as HIPAA and GDPR. Remote patient monitoring through smart drug delivery systems is gaining traction among insurers and integrated care providers who see value in minimizing hospital visits and enabling outcome-based reimbursement models. This digital evolution is not just a technical upgrade-it’s a shift in the care paradigm, where subcutaneous drug delivery becomes a dynamic interface between patients, providers, and data ecosystems.

What’s Powering the Growth Trajectory of This Market Worldwide?

The growth in the subcutaneous drug delivery devices market is driven by several factors rooted in therapeutic advancements, patient behavior, technological progress, and healthcare infrastructure evolution. The increasing global prevalence of chronic diseases, especially diabetes, autoimmune disorders, and cancer, has created a consistent demand for long-term and frequent drug administration, making subcutaneous delivery a preferred route. Aging populations in developed markets, coupled with a rising middle class in emerging economies, are expanding the demand for self-administered treatments. Patient preferences have shifted decisively toward non-invasive, time-efficient, and discreet solutions that minimize clinic visits and maximize autonomy. On the technological front, innovations in biologics have made it possible to deliver large molecule drugs subcutaneously, while device manufacturers are introducing customizable, ergonomic designs to accommodate a broader user base. The rise of biosimilars and combination therapies has also stimulated the need for innovative delivery formats. Meanwhile, governments and private insurers are incentivizing self-administration to curb escalating healthcare costs, further reinforcing the market’s momentum. Additionally, the proliferation of specialty pharmacies and direct-to-patient distribution models is making these devices more accessible. Regulatory support in the form of fast-track approvals for drug-device combination products is expediting market entry, while industry collaborations between pharma companies and medtech firms are accelerating innovation. Collectively, these factors are contributing to a robust and sustained expansion of the subcutaneous drug delivery devices market across both mature and developing healthcare landscapes.

SCOPE OF STUDY:

The report analyzes the Subcutaneous Drug Delivery Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors, Needle-free Injectors); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • 3M
  • AbbVie
  • Amgen
  • AstraZeneca
  • Bayer
  • Becton, Dickinson and Company (BD)
  • Consort Medical Plc
  • Convatec Group
  • Dexcom
  • Elcam Medical Group
  • Eli Lilly and Company
  • Enable Injections
  • Gerresheimer AG
  • Halozyme Therapeutics
  • Inolife Sciences
  • Insulet Corporation
  • Johnson & Johnson
  • Medtronic Plc
  • Merck & Co.
  • Novo Nordisk
  • Pfizer
  • PharmaJet
  • Roche
  • Sanofi
  • Smith & Nephew
  • Terumo Corporation
  • Unilife Corporation
  • United Therapeutics
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Subcutaneous Drug Delivery Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Chronic Diseases Propels Growth in Self-Administered Subcutaneous Therapies
    • Shift Toward Home-Based Care and Remote Patient Management Expands the Addressable Market for Drug Delivery Devices
    • Integration of Digital Health Tools Drives Adoption of Smart and Connected Subcutaneous Injectors
    • Biologic and Biosimilar Pipeline Growth Strengthens the Business Case for Subcutaneous Drug Formulations
    • Patient Preference for Minimally Invasive and Convenient Administration Accelerates Demand for Autoinjectors and Wearables
    • Advances in Micro-Needle and Patch Technologies Generate Opportunities for Needle-Free Drug Delivery Solutions
    • Increasing Geriatric and Pediatric Populations Drive Demand for User-Friendly and Ergonomically Designed Devices
    • Rising Emphasis on Adherence and Outcome-Based Care Strengthens the Business Case for Digital Monitoring Integration
    • Decentralized Clinical Trials and Direct-to-Patient Models Drive Adoption of Portable Drug Delivery Platforms
    • Pharmaceutical Shift Toward Chronic Disease Management Expands Device Applications Across Therapeutic Areas
    • Manufacturing Innovations and Modular Design Trends Sustain Growth Through Scalable and Customizable Solutions
    • Growing Consumer Trust in Self-Care Technologies Generates Long-Term Demand for Subcutaneous Delivery Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Subcutaneous Drug Delivery Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Subcutaneous Drug Delivery Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Subcutaneous Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Prefilled syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Prefilled syringes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Prefilled syringes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pen injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Pen injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Pen injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Auto injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Auto injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Auto injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Wearable injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Wearable injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Wearable injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Needle-free Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Needle-free Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Needle-free Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospital Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospital Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Retail Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Retail Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Online Pharmacies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Online Pharmacies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Subcutaneous Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • JAPAN
    • Subcutaneous Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • CHINA
    • Subcutaneous Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • EUROPE
    • Subcutaneous Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Subcutaneous Drug Delivery Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Subcutaneous Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • FRANCE
    • Subcutaneous Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • GERMANY
    • Subcutaneous Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Subcutaneous Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Subcutaneous Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Subcutaneous Drug Delivery Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Subcutaneous Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Subcutaneous Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • INDIA
    • Subcutaneous Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Subcutaneous Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Subcutaneous Drug Delivery Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Subcutaneous Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Subcutaneous Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Subcutaneous Drug Delivery Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Subcutaneous Drug Delivery Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030
  • AFRICA
    • Subcutaneous Drug Delivery Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Subcutaneous Drug Delivery Devices by Product - Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Subcutaneous Drug Delivery Devices by Product - Percentage Breakdown of Value Sales for Prefilled syringes, Pen injectors, Auto injectors, Wearable injectors and Needle-free Injectors for the Years 2015, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Subcutaneous Drug Delivery Devices by Distribution Channel - Hospital Pharmacies, Retail Pharmacies and Online Pharmacies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Subcutaneous Drug Delivery Devices by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies, Retail Pharmacies and Online Pharmacies for the Years 2015, 2025 & 2030

IV. COMPETITION